Elsesy ME, Moustafa A, Oh-Hohenhorst SJ, Muller C, et al. Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status. Br J Cancer 2026 Jul 7. doi: 10.1038/s41416-026-03518.
PMID: 42414479